Premier (PINC) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Jan, 2026Executive summary
Fiscal 2024 Q4 and full-year results exceeded expectations, driven by technology enablement, supply chain initiatives, and growth in both segments.
Strategic focus on technology-enabled healthcare, smarter supply chain, and divestiture of non-core assets S2S Global and Contigo Health.
Board approved an additional $200 million share repurchase under a $1 billion authorization and continued quarterly dividends.
Expanded partnerships with healthcare providers, achieving 97% GPO retention and 95% SaaS renewal rates.
Leadership transition: CFO Craig McKasson retiring, succeeded by Glenn Coleman.
Financial highlights
Q4 total net revenue: $350.3 million, up 3% year-over-year; full-year net revenue $1,346.4 million, up 1%.
Q4 GAAP net income: $60.6 million; Q4 diluted EPS $0.57, up 217% year-over-year.
Q4 adjusted EBITDA: $118.7 million, down 9%; full-year adjusted EBITDA $445.8 million, down 8%.
Free cash flow for fiscal 2024: $115.7 million, down from $264.4 million, mainly due to $162.3 million in tax payments from a non-healthcare GPO sale.
Cash and cash equivalents as of June 30, 2024: $125.1 million.
Outlook and guidance
Fiscal 2025 guidance: total net revenue $930 million–$1.02 billion; adjusted EBITDA $235 million–$255 million; adjusted EPS $1.16–$1.28.
Guidance excludes Contigo Health and S2S Global contributions and impacts from significant acquisitions or share repurchases.
Supply Chain Services segment revenue (excluding direct sourcing): $560 million–$610 million.
Performance Services segment revenue: $370 million–$410 million.
Free cash flow expected to be 45%–55% of adjusted EBITDA; capital expenditures $90–$100 million; cash tax rate below 5%.
Latest events from Premier
- Q1 net income rose to $72.9M on $248.1M revenue, driven by a $57M legal settlement.PINC
Q1 202516 Jan 2026 - Technology-driven growth, new leadership, and capital returns support long-term value.PINC
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Q2 loss driven by $126.8M impairment; guidance reaffirmed, adjusted EPS outlook raised.PINC
Q2 20259 Jan 2026 - AI-driven supply chain and shared services are key to transformative savings and future growth.PINC
Leerink’s Global Healthcare Conference 202518 Dec 2025 - Definitive merger agreement for $28.25/share cash buyout, board-approved, pending shareholder vote.PINC
Proxy Filing1 Dec 2025 - Shareholders to vote on $28.25 per share all-cash merger, board unanimously recommends approval.PINC
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve executive pay, with strong ESG focus.PINC
Proxy Filing1 Dec 2025 - Shareholders to vote on a $28.25 per share all-cash merger, unanimously backed by the board.PINC
Proxy Filing1 Dec 2025 - Acquisition by Patient Square Capital will take the company private, pending approvals.PINC
Proxy Filing1 Dec 2025